The Business Case for PEGylated Drug Development
For pharmaceutical companies, PEGylation is more than a scientific technique — it is a strategic business decision. Attaching PEG chains to an existing drug can extend its patent life, improve its profile, and create a new marketable product. In an industry where patent cliffs threaten revenue, PEGylation offers a pathway to lifecycle management that benefits both manufacturers and...
0 Reacties 0 aandelen 449 Views 0 voorbeeld